Cargando…
Sensible graphene oxide differentiates macrophages and Leishmania: a bio-nano interplay in attenuating intracellular parasite
Leishmania is an obligate intracellular protozoan parasite, which resides in human macrophage vacuoles that are referred to as parasitophorus vacuoles. Amphotericin B (AmB) is the first-line drug with 99% cure rates; however, overdose-induced toxic side effects are a major limitation. To improve the...
Autores principales: | Singh, Aakriti, Sharma, Sandeep, Yadagiri, Ganesh, Parvez, Shabi, Gupta, Ritika, Singhal, Nitin Kumar, Koratkar, Nikhil, Singh, Om Prakash, Sundar, Shyam, Shanmugam, Vijayakumar, Mudavath, Shyam Lal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055620/ https://www.ncbi.nlm.nih.gov/pubmed/35516949 http://dx.doi.org/10.1039/d0ra04266h |
Ejemplares similares
-
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020) -
Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity
por: Parvez, Shabi, et al.
Publicado: (2020) -
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023) -
Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and Preclinical Study
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2020) -
Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
por: Mudavath, Shyam Lal, et al.
Publicado: (2014)